Page 4 - Managing Directorgv Prasad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19: Dr Reddy s gets DCGI nod for Phase 3 clinical trials for Sputnik V vaccine Earlier this week, the Data and Safety Monitoring Board (DSMB) reviewed safety data from Phase 2 clinical trials of the Sputnik V vaccine for COVID-19, and recommended Phase 3 recruitment. 0 claps Drugs Control General of India (DCGI) to conduct Phase 3 clinical trials for the Sputnik V vaccine for COVID-19. The Phase 3 study of Sputnik V will be conducted on 1,500 subjects as part of the randomised, double-blind, parallel-group, placebo-controlled study in the country, the Hyderabad-based firm said in a regulatory filing. Earlier this week, the Data and Safety Monitoring Board (DSMB) reviewed safety data from the Phase 2 clinical trial of the vaccine and recommended Phase 3 recruitment.

Andhra pradeshMinistry of health russiaGamaleya national research institute of epidemiologyRussian direct investment fundDrugs control generalSafety monitoring boardLaboratories co chairmanManaging directorgv prasadGamaleya national research instituteDr reddy x27s laboratories limitedCorona virusCovid 19 vaccineஆந்திரா பிரதேஷ்அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யாரஷ்ய நேரடி முதலீடு நிதிமருந்துகள் கட்டுப்பாடு ஜநரல்